Business
Eiko Lifesciences Limited Press Release Jun 26 2025
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddhant Kabra
About this update from Eiko Lifesciences Limited
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddhant Kabra View Attachment
View stock analysis, news, and events for Eiko Lifesciences Limited